Lifeward Ltd. achieved a modest revenue increase in Q3 2025, with significant operational improvements reflected in reduced cash burn and operating losses, indicating a focused transformation underway.

• Quarterly revenue rose 8% sequentially to $6.2 million, driven by record ReWalk placements for Medicare beneficiaries.
• Non-GAAP operating loss decreased by 27% year-over-year, signaling improved operational efficiency.
• Established first Medicare Advantage commercial revenue and received CE Mark approval, expanding European market access.
• Implemented a $3 million loan to strengthen liquidity and support the ongoing transformation plan.
• Closed with over 200 systems in backlog and a healthy pipeline of qualified leads in the U.S. and Germany.